Analystreport

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) was given a new $20.00 price target on by analysts at Citigroup Inc.. They now have a "buy" rating on the stock.

Syndax Pharmaceuticals, Inc.  (SNDX) 
Last syndax pharmaceuticals, inc. earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.syndax.com